According to a new report, published by KBV research, The Global Neurovascular Devices Market size is expected to reach $4.2 billion by 2028, rising at a market growth of 8.8% CAGR during the forecast period.
The Hospital & Surgery Centers segment acquired maximum revenue share in the Global Neurovascular Devices Market by End User in 2021 thereby, achieving a market value of $2.8 billion by 2028. The rising patient choice for minimally invasive surgical treatments, an increase in ambulatory surgery centers throughout developed nations, as well as the convenience of scheduling, the clinical staff's focus, increased productivity, and the increased safety and efficacy of these centers, are the key factors anticipated to propel the growth of this end-user segment in the upcoming years.
The Cerebral Balloon Angioplasty & Stenting Systems segment is showcasing a CAGR of 9.5% during (2022 - 2028). Patients suffering from the cerebrovascular disease are treated with cerebral balloon angioplasty and stent placement devices. The systems assist in unblocking obstructed arteries and enhancing cerebral blood flow. This can reduce the severity, including vertigo, headaches, and weakness.
The Cerebral Aneuryms segment is generating highest revenue share in the Global Neurovascular Devices Market by Disease Pathology in 2021 thereby, achieving a market value of $17 billion by 2028. The segment is expanding due to more neurosurgeons using minimally invasive neurosurgery techniques, rising healthcare costs in developing nations, and an increase in risk factors such as high blood pressure, high cholesterol, smoking, diabetes, and obesity.
The North America market dominated the Global Neurovascular Devices Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.6 billion by 2028. The Europe market is exhibiting a CAGR of 8.1% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 9.6% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/neurovascular-devices-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.
By End User
By Technology
By Disease Pathology
By Geography
Companies Profiled
Unique Offerings 
